Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | A$138.36B | 32.6x | 1.59 | A$285.69 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ | |
Resmed DRC | Sydney | Healthcare | Healthcare Equipment & Supplies | A$55.24B | 31.1x | 1.35 | A$37.69 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.9% Upside | Upgrade to Pro+ | |
Pro Medicus Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | A$26.85B | 324.2x | 8.79 | A$256.94 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -29.9% Downside | Upgrade to Pro+ | |
Fisher&Paykel Healthcare | Sydney | Healthcare | Healthcare Equipment & Supplies | A$20.12B | 124.3x | -3.83 | A$34.33 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.8% Upside | Upgrade to Pro+ | |
Cochlear | Sydney | Healthcare | Healthcare Equipment & Supplies | A$19.63B | 54.9x | 2.87 | A$299.80 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.2% Upside | Upgrade to Pro+ | |
Sonic Healthcare | Sydney | Healthcare | Healthcare Providers & Services | A$13.57B | 26.3x | -0.99 | A$28.25 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.3% Upside | Upgrade to Pro+ | |
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$8.26B | 162.6x | 0.82 | A$24.68 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.8% Upside | Upgrade to Pro+ | |
Ramsay Health Care | Sydney | Healthcare | Healthcare Providers & Services | A$8.07B | 9.2x | 0.15 | A$35.21 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.9% Upside | Upgrade to Pro+ | |
Ramsay Health Care Pref | Sydney | Healthcare | Healthcare Providers & Services | A$8.05B | 9.2x | A$107.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ebos | Sydney | Healthcare | Pharmaceuticals | A$6.55B | 24x | 3.82 | A$33.68 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.7% Upside | Upgrade to Pro+ | |
Ansell | Sydney | Healthcare | Healthcare Equipment & Supplies | A$4.93B | 35.8x | -0.81 | A$34.06 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.7% Downside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | A$4.67B | -1,490x | 12.36 | A$2.97 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -33.3% Downside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | A$3.36B | -20.5x | -1.67 | A$2.94 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -34% Downside | Upgrade to Pro+ | |
Summerset Group | Sydney | Healthcare | Healthcare Providers & Services | A$2.84B | 7.7x | 0.15 | A$12 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regis Healthcare Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$1.93B | -90.1x | -3.45 | A$6.42 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Pharmaceuticals | A$1.53B | 13x | 0.12 | A$11.99 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Polynovo | Sydney | Healthcare | Healthcare Equipment & Supplies | A$1.41B | 255x | 1.31 | A$2.05 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40% Upside | Upgrade to Pro+ | |
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$1.27B | -44.3x | 0.49 | A$4.15 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Primary Health Care | Sydney | Healthcare | Healthcare Providers & Services | A$1.03B | -1.5x | 0.03 | A$1.42 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7% Downside | Upgrade to Pro+ | |
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | A$960.25M | -1.4x | 0.37 | A$0.78 | 5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanosonics | Sydney | Healthcare | Healthcare Equipment & Supplies | A$916.71M | 69.8x | -1.98 | A$3.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | A$823.31M | -50.3x | 3.59 | A$0.45 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.1% Upside | Upgrade to Pro+ | |
Paragon Care Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | A$769.72M | 52.8x | -2.82 | A$0.47 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.2% Upside | Upgrade to Pro+ | |
Integral Diagnostics Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$692.39M | -11.3x | 0.03 | A$2.97 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16% Upside | Upgrade to Pro+ | |
Australian Clinical Labs | Sydney | Healthcare | Healthcare Providers & Services | A$673.16M | 28.2x | -0.86 | A$3.44 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$615.92M | -13.8x | 0.45 | A$1.32 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$590.87M | 16.5x | 0.93 | A$11.81 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | A$506.19M | -9.6x | -0.6 | A$0.34 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ebr Systems DRC | Sydney | Healthcare | Healthcare Equipment & Supplies | A$505.90M | -4.4x | 0.69 | A$1.39 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.8% Upside | Upgrade to Pro+ | |
Monash IVF Group Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$497.95M | -75.3x | 0.58 | A$1.28 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.2% Upside | Upgrade to Pro+ |